FindTrial
Sign In

A comparison of bethanechol chloride and artificial saliva in the management of xerostomia in patients with cancer

A comparison of bethanechol chloride and artificial saliva in the management of xerostomia in patients with cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN83877765
Enrollment
54
Registered
2004-09-30
Start date
2002-10-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive System: Xerostomia Digestive System Xerostomia

Interventions

Participants will be randomised to one week's treatment with: 1. Bethanechol chloride or 2. Saliva Orthana

Sponsors

Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 54 patients >18 years advanced cancer, xerostomia Eastern Cooperative Oncology Group (ECOG) status 0-3

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
Not provided at time of registration—

Secondary

MeasureTime frame
Not provided at time of registration—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026